OVID — Ovid Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Ovid Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	188	129	106	53.1	69.6
Net Total Accounts Receivable
Net Total Receivables	0	—	—	—	—
Prepaid Expenses
Total Current Assets	190	131	110	55.9	74.4
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.243	16.1	14.7	13.2	11.9
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	195	155	144	92.2	151
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	14.8	6.99	11.5	10.5	8.29
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	14.8	23	56.2	23.9	20.3
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	180	132	87.8	68.2	131
Total Liabilities & Shareholders' Equity	195	155	144	92.2	151
Total Common Shares Outstanding
Total Preferred Shares Outstanding